ITI Funds RTS Equity UCITS ETF SICAV

PhysicalIndex replication
DividendDistribution policy
1.07 %TER
£3.54M Fund size
—Number of positions
4.23 % TD
—Top 10 share
USDCurrency
4SRI

Current price

£22.80
19 Nov 2026
1D
1W
1M
3M
6M
1Y
3Y
Max

Description

The investment objective of the Fund is to track both the upward and downward evolution of the RTS Index (code Bloomberg: RTSI$ Index) («Benchmark Index») based on Russian stocks chosen for market size, liquidity, and industry group representation. RTS Index (the «Index») is capitalization-weighted composite index with free-float coefficients based on the most liquid Russian equity securities of largest Russian issuers admitted to trading on the Moscow Exchange. The Index tracks the performance of constituent securities in USD. The Fund seeks to achieve its objective via investments in equity securities of RTS Index. These equity securities include common and preferred stocks. Updated composition of the Fund holdings is available on itifunds-etf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the Fund, and might also be mentioned on the websites of the stock exchanges where the Fund is listed. Invested financial instruments: Russian common and preferred stocks. Dividend policy: the funds amounts available for distribution (if any) will be distributed. Net Asset Value: is daily calculated providing that the relevant stock exchanges are open for trading and orders can be covered. Redemptions: Investors are able to redeem their shares on the primary market every valuation day before 13:00 CET and sell their shares on the secondary market at any time during trading hours of the Funds listing places. The base currency of the Fund is USD. The anticipated level of the tracking error under normal market conditions is expected to be 2.0%.

Return

Here you can see the performance (incl. distributions) of the ITI Funds RTS Equity UCITS ETF SICAV.

Period Perfor­mance
1 Week-46.95 %
1 Month-41.11 %
3 Months-54.10 %
6 Months-52.50 %
1 Year-42.42 %
3 Years-32.68 %(-12.36 % p.a.)
5 Years—
10 Years—
Since inception -28.84 %(-8.02 % p.a.)
Year Perfor­mance
YTD-51.93 %
2025—
2024—
2023—
2022-8.22 %
2021+28.27 %
As of: 24 Feb 2022. Performance displayed in GBP

Master data

Key master data for the ITI Funds RTS Equity UCITS ETF SICAV

Total expense ratio (TER) 1.07 %
Index replication Physical
Replication method Full
Distribution policy Dividend
Fund size £3.54M
Fund launch 30 Jan 2018
Fund currency USD
Currency hedging No 
Fund domicileLuxemburg
Risk indicator (SRI)
4 · medium risk class

Distributions

From the table you can see the distributions or the reinvested tax portions of the ETF.

PeriodAmountDistribution yield
2026 (Prognose)— —
2025 — —
2024 — —
2023 — —
2022 — —

Risk metrics

Key risk and analysis metrics for the ITI Funds RTS Equity UCITS ETF SICAV

Volatility
20.15 % 1 Year
24.42 % 3 Years
— 5 Years
max. Drawdown
-20.63 % 1 Year
-34.38 % 3 Years
— 5 Years
Sharpe Ratio
0.56 1 Year
0.44 3 Years
— 5 Years
XLM
—

Information about the RTS RTSI TR USD Index

Index name RTS RTSI TR USD (1)
Included securities —
Stock positions —
Bond positions —
Cash and other positions 0

More ETFs tracking the RTS RTSI TR USD Index

Here you can find alternative index funds for the RTS RTSI TR USD.

Fund nameWKNTER
No results

Frequently asked questions

Here you will find all answers to your questions about the ITI Funds RTS Equity UCITS ETF SICAV

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.